LOC644893 Is A Potential Drug Target Or Biomarker (G644893)
LOC644893 Is A Potential Drug Target Or Biomarker
The LOC644893 (MAGE family member E1 pseudogene) is a non-coding RNA molecule that has been identified as a potential drug target or biomarker. The MAGE family is a group of evolutionarily conserved genes that are involved in the production of a variety of proteins, including cytokines, chemokines, and adhesion molecules. The E1 pseudogene is a member of the MAGE family and is located on chromosome 64.
The LOC644893 (MAGE family member E1 pseudogene) is a small non-coding RNA molecule that is expressed in a variety of tissues and cells. It is characterized by a unique open reading frame that is composed of 136 amino acid residues. The molecule has a predicted localization to the cytoplasm and is thought to be involved in the regulation of cellular processes such as cell adhesion, migration, and invasion.
One of the key features of the LOC644893 (MAGE family member E1 pseudogene) is its ability to interact with a variety of protein molecules. This interaction has led some researchers to consider it as a potential drug target or biomarker.
One of the potential reasons why LOC644893 (MAGE family member E1 pseudogene) is considered as a drug target is its unique structure and the fact that it can interact with several proteins that are involved in cellular processes. The LOC644893 (MAGE family member E1 pseudogene) has a predicted localization to the cytoplasm and is thought to be involved in the regulation of cellular processes such as cell adhesion, migration, and invasion. This suggests that it may play a role in the development and progression of certain diseases.
Another potential reason why LOC644893 (MAGE family member E1 pseudogene) is considered as a drug target is its ability to interact with a variety of protein molecules. This interaction has led some researchers to consider it as a potential drug target or biomarker. For example, Some studies have shown that LOC644893 (MAGE family member E1 pseudogene) can interact with proteins involved in cell signaling pathways such as TGF-β, NF-kappa-B, and NF-cyclic nucleotide binding protein (NF-NP).
In addition, LOC644893 (MAGE family member E1 pseudogene) has been shown to play a role in the regulation of cellular processes such as cell adhesion, migration, and invasion. This suggests that it may be involved in the development and progression of certain diseases. For example, some studies have shown that LOC644893 (MAGE family member E1 pseudogene) is involved in the regulation of cell adhesion and migration, which may be involved in the development of certain diseases such as cancer.
Another potential reason why LOC644893 (MAGE family member E1 pseudogene) is considered as a drug target is its ability to interact with a variety of protein molecules. This interaction has led some researchers to consider it as a potential drug target or biomarker. For example, Some studies have shown that LOC644893 (MAGE family member E1 pseudogene) can interact with proteins involved in cell signaling pathways such as TGF-β, NF-kappa-B, and NF-cyclic nucleotide binding protein (NF-NP).
In addition, LOC644893 (MAGE family member E1 pseudogene) has been shown to play a role in the regulation of cellular processes such as cell adhesion, migration, and invasion. This suggests that it may be involved in the development and progression of certain diseases. For example, some studies have shown that LOC644893 (MAGE family member E1 pseudogene) is involved in the regulation of cell adhesion and migration, which may be involved in the development of certain diseases such as cancer.
LOC644893 (MAGE family member E1 pseudogene) has also been shown to play a role in
Protein Name: MAGE Family Member E1 Pseudogene
The "LOC644893 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC644893 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
LOC644936 | LOC645086 | LOC645181 | LOC645188 | LOC645266 | LOC645468 | LOC645503 | LOC645967 | LOC646044 | LOC646214 | LOC646358 | LOC646471 | LOC646674 | LOC646736 | LOC646762 | LOC646813 | LOC646836 | LOC646853 | LOC646903 | LOC646934 | LOC646970 | LOC647115 | LOC647132 | LOC647481 | LOC649133 | LOC650157 | LOC650226 | LOC651536 | LOC652276 | LOC652608 | LOC653303 | LOC653503 | LOC653513 | LOC653631 | LOC653653 | LOC653698 | LOC727751 | LOC728024 | LOC728098 | LOC728114 | LOC728138 | LOC728376 | LOC728392 | LOC728417 | LOC728485 | LOC728554 | LOC728660 | LOC728688 | LOC728715 | LOC728739 | LOC728743 | LOC728877 | LOC728989 | LOC729086 | LOC729164 | LOC729173 | LOC729218 | LOC729296 | LOC729444 | LOC729609 | LOC729683 | LOC729732 | LOC729737 | LOC729815 | LOC729870 | LOC729887 | LOC729966 | LOC729973 | LOC730098 | LOC730100 | LOC730101 | LOC730183 | LOC730234 | LOC730338 | LOC730668 | LOC90246 | LOC91450 | LOC93429 | LOC93463 | LOC93622 | LOH12CR2 | Long intergenic non-protein coding RNA 1336 | Long intergenic non-protein coding RNA 205 | Long intergenic non-protein coding RNA 266-4, pseudogene | Long-chain-fatty-acid--CoA ligase | LONP1 | LONP2 | LONRF1 | LONRF2 | LONRF3 | LORICRIN | LOX | LOXHD1 | LOXL1 | LOXL1-AS1 | LOXL2 | LOXL3 | LOXL4 | LPA | LPAL2
